oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2019 ( 35 )

2018 ( 42 )

2017 ( 61 )

2016 ( 94 )

Custom range...

Search Results: 1 - 10 of 14017 matches for " Shivaram Singh "
All listed articles are free for downloading (OA Articles)
Page 1 /14017
Display every page Item
Comparison of entecavir and telbivudine in management of chronic Hepatitis B
Singh Shivaram
Hepatitis B Annual , 2008,
Abstract: The currently available options for the treatment of chronic hepatitis B virus (HBV) infection include standard and pegylated interferon alfa and four oral antiviral agents (lamivudine, adefovir, entecavir, and telbivudine). These treatment strategies are either therapies of finite duration which aim to achieve sustained off-therapy responses or long term treatments that aim to maintain on-therapy remission. Most agents designed to target hepatitis B are hindered by the development of resistance, poor tolerability or limited efficacy; therefore, new agents and treatment strategies are needed. Pegylated interferon alfa may offer higher sustained off-therapy responses after one year, but most patients do not respond. Oral antivirals are the only candidates for long term treatment of patients with chronic HBV infection. Viral suppression has favorable effects on outcome outcome and modifies the natural history of the disease. The oral nucleos(t)ide analogues are generally better tolerated than interferon. This article attempts to provide an overview of the data available on the two new drugs entecavir and telbivudine.
Management of chronic hepatitis B infection: Miles to go...
Singh Shivaram
Hepatitis B Annual , 2005,
Abstract:
Hepatitis B Eradication Day: It′s never too late!!
Singh Shivaram
Hepatitis B Annual , 2006,
Abstract:
Hepatitis B vaccine induced HBsAg positivity
Singh Shivaram
Hepatitis B Annual , 2007,
Abstract: Hepatitis B vaccine can induce transient hepatitis B surface antigen positivity not only in adult hemodialysis patients but also in normal adults and children. Hence hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive carrier. Hence blood donors should not donate blood in this early post-vaccination period and renal dialysis patients should not be screened for hepatitis B surface antigen for at least 21 to 28 days after hepatitis B vaccination. These guidelines could prevent individuals in the early post-inoculation period from being erroneously labeled as having hepatitis B viral infection.
Hepatitis B Immunization: FAQs
Singh Shivaram
Hepatitis B Annual , 2004,
Abstract:
I wish I had AIDS
Singh Shivaram
Hepatitis B Annual , 2008,
Abstract:
Hepatitis B virus serology: Use and interpretation
Shah Sunil,Singh Shivaram
Hepatitis B Annual , 2007,
Abstract: Hepatitis B is a well-recognized global public health problem. It is estimated that nearly 2 billion people around the world have serologic evidence of past or present hepatitis B virus (HBV) infection, while 350 million people are chronically infected. This worldwide burden of hepatitis B mandates accurate and timely diagnosis of patients infected with HBV and the use of treatment strategies derived from evidence-based guidelines. HBV is a DNA virus that produces a series of viral protein products. Serologic and nucleic acid testing are critical to disease prevention and treatment objectives. Information from such testing helps determine patients′ infectivity and immune status, appropriate monitoring strategies, and the efficacy of treatment, as well as providing data that contributes to a better understanding of the natural history and epidemiology of the disease. This article reviews the clinical use of serologic and nucleic acid tests as markers of disease activity.
Treatment of chronic hepatitis B: A bridge too far
Singh Shivaram,Chawla Yogesh
Hepatitis B Annual , 2006,
Abstract:
Hepatitis B viral infection: Emerging issues
Singh Shivaram,Chawla Yogesh
Hepatitis B Annual , 2007,
Abstract:
Hepatitis B viral infection: From aborting transmission to liver transplantation - Awareness is the key
Singh Shivaram,Chawla Yogesh
Hepatitis B Annual , 2009,
Abstract:
Page 1 /14017
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.